Literature DB >> 21529592

Targeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

M Talelli1, M Iman, C J F Rijcken, C F van Nostrum, W E Hennink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21529592     DOI： 10.1016/j.jconrel.2010.07.092

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  7 in total

1.  Biological characterization of a novel hybrid copolymer carrier system based on glycogen.

Authors:  Markéta Jirátová; Aneta Pospíšilová; Maria Rabyk; Martin Pařízek; Jan Kovář; Andrea Gálisová; Martin Hrubý; Daniel Jirák
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 2.  EGF receptor-targeted nanocarriers for enhanced cancer treatment.

Authors:  Alyssa M Master; Anirban Sen Gupta
Journal:  Nanomedicine (Lond)       Date:  2012-12       Impact factor: 5.307

Review 3.  Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers.

Authors:  Yuanpei Li; Kai Xiao; Wei Zhu; Wenbin Deng; Kit S Lam
Journal:  Adv Drug Deliv Rev       Date:  2013-09-21       Impact factor: 15.470

4.  Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.

Authors:  Ke Wang; Lina Liu; Tao Zhang; Yong-liang Zhu; Fuming Qiu; Xian-guo Wu; Xiao-lei Wang; Fu-qiang Hu; Jian Huang
Journal:  Int J Nanomedicine       Date:  2011-12-06

5.  Acid-triggered core cross-linked nanomicelles for targeted drug delivery and magnetic resonance imaging in liver cancer cells.

Authors:  Xian Li; Hao Li; Wei Yi; Jianyu Chen; Biling Liang
Journal:  Int J Nanomedicine       Date:  2013-08-12

Review 6.  Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.

Authors:  Yaozhong Hu; Changxiao Liu; Serge Muyldermans
Journal:  Front Immunol       Date:  2017-11-02       Impact factor: 7.561

7.  PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses.

Authors:  Eduardo Ruiz-Hernández; Michael Hess; Gustavo J Melen; Benjamin Theek; Marina Talelli; Yang Shi; Burcin Ozbakir; Erik A Teunissen; Manuel Ramírez; Diana Moeckel; Fabian Kiessling; Gert Storm; Hans W Scheeren; Wim E Hennink; Aladar A Szalay; Jochen Stritzker; Twan Lammers
Journal:  Polym Chem       Date:  2014-03-07       Impact factor: 5.582
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.